Get startedLog in
    Picture of Aditxt logo

    ADTX — Aditxt News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Aditxt's Subsidiary Pearsanta Acquires MDNA Life Sciences' Proprietary Mitomic Testing Platform

    Picture of Aditxt logoAditxt
    08/01/2024 17:43
    Jan 8 (Reuters) - Aditxt Inc  ADTX.O :
    * ADITXT, INC.’S SUBSIDIARY PEARSANTA, INC. ACQUIRES MDNA
LIFE
SCIENCES INC.’S PROPRIETARY MITOMIC™ TESTING PLATFORM PIONEERING
EARLY DISEASE AND CANCER DETECTION IN A TRANSACTION VALUED AT
APPROXIMATELY $25 MILLION
    * ADITXT INC - PROPOSED DEAL FOR, TRANSACTION VALUED AT
APPROXIMATELY $25 MILLION

Source text for Eikon:  ID:nBwbY9C5sa 
Further company coverage:  ADTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Aditxt

    See all news